全文获取类型
收费全文 | 3149442篇 |
免费 | 224898篇 |
国内免费 | 6554篇 |
专业分类
耳鼻咽喉 | 41603篇 |
儿科学 | 102780篇 |
妇产科学 | 85302篇 |
基础医学 | 440502篇 |
口腔科学 | 89513篇 |
临床医学 | 280278篇 |
内科学 | 604892篇 |
皮肤病学 | 67644篇 |
神经病学 | 251236篇 |
特种医学 | 125226篇 |
外国民族医学 | 698篇 |
外科学 | 476642篇 |
综合类 | 73564篇 |
现状与发展 | 11篇 |
一般理论 | 1073篇 |
预防医学 | 242405篇 |
眼科学 | 73688篇 |
药学 | 232951篇 |
9篇 | |
中国医学 | 8373篇 |
肿瘤学 | 182504篇 |
出版年
2021年 | 24383篇 |
2019年 | 23974篇 |
2018年 | 52123篇 |
2017年 | 40277篇 |
2016年 | 45376篇 |
2015年 | 34975篇 |
2014年 | 47171篇 |
2013年 | 68490篇 |
2012年 | 99743篇 |
2011年 | 115875篇 |
2010年 | 73820篇 |
2009年 | 63799篇 |
2008年 | 106729篇 |
2007年 | 113352篇 |
2006年 | 95743篇 |
2005年 | 93646篇 |
2004年 | 91921篇 |
2003年 | 88197篇 |
2002年 | 83648篇 |
2001年 | 142406篇 |
2000年 | 146510篇 |
1999年 | 122575篇 |
1998年 | 33805篇 |
1997年 | 30002篇 |
1996年 | 29758篇 |
1995年 | 28722篇 |
1994年 | 26702篇 |
1993年 | 24786篇 |
1992年 | 96686篇 |
1991年 | 94019篇 |
1990年 | 91111篇 |
1989年 | 87858篇 |
1988年 | 80931篇 |
1987年 | 79302篇 |
1986年 | 75344篇 |
1985年 | 72308篇 |
1984年 | 53570篇 |
1983年 | 46055篇 |
1982年 | 26609篇 |
1979年 | 49615篇 |
1978年 | 34267篇 |
1977年 | 29156篇 |
1976年 | 27336篇 |
1975年 | 28928篇 |
1974年 | 35281篇 |
1973年 | 33881篇 |
1972年 | 31298篇 |
1971年 | 29330篇 |
1970年 | 27151篇 |
1969年 | 25435篇 |
排序方式: 共有10000条查询结果,搜索用时 11 毫秒
71.
72.
Chih-Wei Hsu Sheng-Yu Lee Yao-Hsu Yang Liang-Jen Wang 《The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)》2020,23(10):653
BackgroundGeneric antidepressants are approved on the market based on evidence of bioequivalence to their brand-name versions. We aimed to assess whether generic antidepressants exert equal effectiveness as their brand-name counterparts for treating patients with depressive disorders.MethodsIn a nationwide, population-based cohort in Taiwan from 1997 through 2013, patients with a diagnosis of a depressive disorder aged between 18 and 65 years who were new users of antidepressant drugs were classified into either the brand-name group or the generic group. All patients were followed up until medication discontinuation or the end of the study period. We assessed the risk for hospitalization as a primary outcome and augmentation therapy, daily dose, medication discontinuation, or switching to another antidepressant as secondary outcomes.ResultsA total of 277 651 brand-name users (35.8% male; mean age: 41.2 years) and 270 583 generic users (35.8% male; mean age: 41.0 years) were divided into 10 different antidepressant groups (fluoxetine, sertraline, paroxetine, escitalopram, citalopram, venlafaxine, mirtazapine, moclobemide, imipramine, and bupropion). We found that patients treated with the generic form of sertraline, paroxetine, escitalopram, venlafaxine, mirtazapine, and bupropion demonstrated significantly higher risks of psychiatric hospitalization (adjusted hazard ratios ranged from 1.20–2.34), compared to their brand-name counterparts. The differences between brand-name antidepressants and their generic counterparts in secondary outcomes varied across different drugs.ConclusionsCompared to most generic antidepressants, brand-name drugs exhibited more protective effects on psychiatric hospitalization for depressive patients. These findings could serve as an important reference for clinicians when encountering patients with depressive disorder. 相似文献
73.
74.
75.
76.
77.
78.
79.
Eric S. Zhou Larissa Nekhlyudov Sharon L. Bober 《Translational andrology and urology》2015,4(2):218-231
There is a large and growing population of long-term cancer survivors. Primary care physicians (PCPs) are playing an increasingly greater role in the care of these patients across the continuum of cancer survivorship. In this role, PCPs are faced with the responsibility of managing a range of medical and psychosocial late effects of cancer treatment. In particular, the sexual side effects of treatment which are common and have significant impact on quality of life for the cancer survivor, often go unaddressed. This is an area of clinical care and research that has received increasing attention, highlighted by the presentation of this special issue on Cancer and Sexual Health. The aims of this review are 3-fold. First, we seek to overview common presentations of sexual dysfunction related to major cancer diagnoses in order to give the PCP a sense of the medical issues that the survivor may present with. Barriers to communication about sexual health issues between patient/PCPs in order are also described in order to emphasize the importance of PCPs initiating this important conversation. Next, we provide strategies and resources to help guide the PCP in the management of sexual dysfunction in cancer survivors. Finally, we discuss case examples of survivorship sexual health issues and highlight the role that a PCP can play in each of these case examples. 相似文献
80.
E. Likotrafiti K. M. Tuohy G. R. Gibson R. A. Rastall 《International journal of food sciences and nutrition》2016,67(2):83-91
The aim of the present study was to evaluate the antimicrobial activity of two synbiotic combinations, Lactobacillus fermentum with short-chain fructooligosaccharides (FOS-LF) and Bifidobacterium longum with isomaltooligosaccharides (IMO-BL), against enterohaemorrhagic Escherichia coli O157:H7 and enteropathogenic E. coli O86. Antimicrobial activity was determined (1) by co-culturing the synbiotics and pathogens in batch cultures, and (2) with the three-stage continuous culture system (gut model), inoculated with faecal slurry from an elderly donor. In the co-culture experiments, IMO-BL was significantly inhibitory to both E. coli strains, while FOS-LF was slightly inhibitory or not inhibitory. Factors other than acid production appeared to play a role in the inhibition. In the gut models, both synbiotics effectively inhibited E. coli O157 in the first vessel, but not in vessels 2 and 3. E. coli O86 was not significantly inhibited. 相似文献